Preventing VTE in Total Knee and Hip Arthroplasty Patients
| Upon completion of this educational activity, the participant should be able to: | ||
| ||
| 1. | | Review guidelines, consensus standards, and requirements for venous thromboembolism (VTE) prophylaxis in total hip arthroplasty (THA) and total knee arthroplasty (TKA) patients. |
| ||
| 2. | | Evaluate how to apply the latest clinical practice guidelines on the prevention of VTE for patients who undergo THA and TKA. |
| ||
| 3. | | Assess the safety and efficacy of existing and emerging anticoagulants for the prevention of VTE. |
| ||
| 4. | | Discuss how emerging oral anticoagulants may impact the prevention of VTE in THA and TKA patients. This activity is supported through an educational grant from Ortho-McNeil Inc. |
| ||
No comments:
Post a Comment